| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 08/01/2007 | CN101007851A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 08/01/2007 | CN101007850A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 08/01/2007 | CN101007777A (s)-(-)-5-tributyltin-N-[(1-allyl-2-pyrrolidinyl)methyl]-2,3-dimethoxybenzamide preparation method |
| 08/01/2007 | CN101007176A Drug for treating rheumatoid, rheumatic and other bone and joint diseases |
| 07/31/2007 | US7250525 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 07/31/2007 | US7250152 Supercritical fluids processing: preparation of protein microparticles and their stablilisation |
| 07/26/2007 | WO2007085026A2 Compositions and methods for the direct therapy of tumors |
| 07/26/2007 | WO2006088958A8 Encapsulated (chelate or ligand) dendritic polymers |
| 07/26/2007 | WO2006067376A3 Radiolabelled conjugates of rgd-containing peptides and methods for their preparation via click-chemistry |
| 07/26/2007 | WO2005084158A3 Polypeptide transduction and fusogenic peptides |
| 07/26/2007 | US20070172423 Composition and method for modulating vasculogenesis for angiogenesis |
| 07/26/2007 | US20070172422 Exponential pattern recognition based cellular targeting compositions, methods and anticancer applications |
| 07/26/2007 | US20070172421 Substituted pyrrolidine-2-ones |
| 07/26/2007 | US20070172420 Ligands |
| 07/25/2007 | EP1809615A2 Lamotrigine analogs |
| 07/25/2007 | EP1809351A2 Container with constrained quality maintenance agent |
| 07/25/2007 | EP1809339A2 Compounds, kits and methods for use in medical imaging |
| 07/25/2007 | EP1809338A1 Method for continuous visualization of a blood clot or plaque in a body lumen |
| 07/25/2007 | EP1809332A2 Compositions for multi-step delivery of hot-spots radiation to cancer cells |
| 07/25/2007 | EP1073475B1 Improvements in or relating to diagnostic/therapeutic agents |
| 07/25/2007 | CN101003526A Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 07/25/2007 | CN101002952A Contrast medium for gastrointestinal tract |
| 07/24/2007 | US7247501 Imaging and targeting tumors using sickle cells |
| 07/24/2007 | CA2331348C Positron emission tomography using gallium-68 chelates |
| 07/19/2007 | US20070168012 Coated implantable medical device |
| 07/19/2007 | US20070166382 Bioresponsive polymer system for delivery of microbicides |
| 07/19/2007 | US20070166229 Cardiovascular safety assay |
| 07/19/2007 | US20070166228 Neutral labeling reactants and conjugates derived thereof |
| 07/19/2007 | US20070166227 Crowned dithiocarbamate metal complexes and methods for their use |
| 07/18/2007 | EP1808184A2 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
| 07/18/2007 | EP1807119A2 Pet and magnetic resonance for screening alzheimer's disease therapeutics |
| 07/18/2007 | CN1326878C Anti human non-Hodgkin's lymphoma chimeric antibody and its derivative and application |
| 07/18/2007 | CN1326877C Specific antibody fragments for the human carcinoembryonic antigen (CEA) |
| 07/18/2007 | CN1326567C Egg yolk antibody composition for preventing and treating atypical pneumonia and its preparation method |
| 07/18/2007 | CN101001647A Virtual colonoscopy with radiolabeled phospholipid ether analogs |
| 07/18/2007 | CN100998877A Application of 99Tcm-SytI-C2A labelled compound used in vulnerable scleratheroma plague development |
| 07/18/2007 | CN100998876A Application of 99Tcm-Syt I-C2A labelled compound as imaging agent used in detecting malignant tumour cell after chemical therapy |
| 07/17/2007 | US7244722 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 07/17/2007 | US7244705 Polyacid glycopeptide derivatives |
| 07/17/2007 | US7244412 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 07/17/2007 | US7244411 Isolating peptides not containing His or Arg and determining concentration involving hydrolysis; chemical modification of alpha and epsilon amino groups; isolation by cation exchange chromatography; identification by mass spectrometry; differential isotopic labeling and relative quantification |
| 07/17/2007 | US7244410 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 07/17/2007 | CA2170879C Diagnostic uses of hydrazinoadenosines |
| 07/12/2007 | WO2007077209A1 Radicicol derivatives useful for positron emission tomography |
| 07/12/2007 | WO2007027385A3 F-18 peptides for pre targeted positron emission tomography imaging |
| 07/12/2007 | WO2006025995A3 Compositions and methods using md-2 mutants and chimeric proteins |
| 07/12/2007 | WO2005037232A3 Methods and compositions for modulating adipocyte function |
| 07/12/2007 | WO2003077723A3 Methods and devices for detection and therapy of atheromatous plaque |
| 07/12/2007 | US20070161781 Therapeutic human albumin solutions with low prekallicrein activator (pka) activity and process for obtaining them |
| 07/12/2007 | US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders |
| 07/12/2007 | US20070160535 Neoplasia, ovarian cancer and skin cancer; radiolabelling |
| 07/12/2007 | US20070160534 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands |
| 07/12/2007 | US20070160533 vascular endothelial growth factor receptor (VEGFR)-binding polypeptides, comprising a fibronectin type III tenth (10Fn3) domain of 80 to 150 amino acids; Angiogenesis |
| 07/12/2007 | US20070160532 Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide |
| 07/12/2007 | US20070160531 Targeting endothelium for tissue-specific delivery of agents |
| 07/12/2007 | US20070160530 Antibodies and molecules derived therefrom that bind to steap-1 proteins |
| 07/12/2007 | US20070160529 Radioimmunoconjugates for targeted alpha therapy |
| 07/12/2007 | US20070160528 Method to evaluate the likelehood of development of bone metastasis based on the determination of calcium binding proteins |
| 07/12/2007 | US20070160527 Use of n-acetyl-d-aminoglycosamine in treatment of local lesions or systematic symptoms related to autoimmune reactions |
| 07/12/2007 | US20070160526 Detection, monitoring and treatment of cancer |
| 07/11/2007 | EP1804657A2 Method for monitoring early treatment response |
| 07/11/2007 | EP1388013B1 Compositions and methods for the use of fibronectin fragments in the diagnosis of cancer |
| 07/11/2007 | CN1995020A Radioactive iodine-17- allylamino-17-demethoxygeldanamycin and its preparation method |
| 07/11/2007 | CN1325933C Radioactive emission detector with position tracking system and application in therapeutical system and treatment process |
| 07/10/2007 | US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety |
| 07/10/2007 | CA2098849C Control of gene expression by ionizing radiation |
| 07/05/2007 | WO2007075912A2 A system and method of administering a therapeutic material to brain tissue |
| 07/05/2007 | WO2007074786A1 Probe for diagnosis of conformational disease |
| 07/05/2007 | WO2007044321A3 Latent procytotoxins and uses thereof |
| 07/05/2007 | WO2007008566A3 Inorganic shell-based radionuclide nanoparticles bound to biomolecules |
| 07/05/2007 | WO2007008232A3 Locoregional internal radionuclide ablation of abnormal tissues. |
| 07/05/2007 | US20070155976 Prosthetic groups useful in the synthesis of radiopharmaceutical compounds |
| 07/05/2007 | US20070154394 Diagnostic agents for pancreatic exocrine function |
| 07/05/2007 | US20070154392 treating a cancerous disease which includes characterizing a disease by an overexpression of one or more somatostatin receptors, exposing such somatostatin receptors to a pharmaceutical formulation containing a somatostatin analogue which binds to the one or more somatostatin receptor |
| 07/05/2007 | US20070154391 Monoclonal antibodies; hybridomas; competitive binding |
| 07/05/2007 | US20070154390 Nuclear molecular imaging contrast agent |
| 07/05/2007 | US20070153954 Radium target and method for producing it |
| 07/05/2007 | CA2634217A1 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof |
| 07/05/2007 | CA2633070A1 Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
| 07/04/2007 | EP1803810A1 Integrin antagonists |
| 07/04/2007 | EP1803711A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 07/04/2007 | EP1802352A1 Use of vcam-1 ligands for detecting and/or treating cardiovascular diseases |
| 07/04/2007 | EP1620134B1 Microwave method for preparing radiolabelled gallium complexes |
| 07/04/2007 | CN1323724C Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG) - solution |
| 07/03/2007 | US7238786 For use in diagnosis and therapy |
| 07/03/2007 | US7238785 Antibody binding to glycoprotein; therapy, diagnosis of cancer |
| 07/03/2007 | US7238340 Monoamine, diamide, thiol-containing metal chelating agents |
| 07/03/2007 | US7238339 Chelate metal ions that can be detected either by their paramagnetic or radioactive properties; diagnostic and therapeutic agents |
| 07/03/2007 | US7238338 Antioxidant, such as ethanol and/or ascorbic acid added to the radiolabeled compound during its preparation and/or storage, allows retention of biological or chemical activity of the radiohalogen-labeled compound such as nucleosides, nucleotides |
| 07/03/2007 | CA2297399C Method for detection of fibrin clots |
| 07/03/2007 | CA2265426C Method for preparing [f-18]-fluoride ion |
| 06/28/2007 | WO2007073200A1 Pet radiotracers |
| 06/28/2007 | WO2007007100A3 Measurement of gastric acid secretion |
| 06/28/2007 | WO2005113601A8 Antibodies and molecules derived therefrom that bind to steap-1 proteins |
| 06/28/2007 | US20070150047 Implantable medical device with bioabsorbable coating |
| 06/28/2007 | US20070149769 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) |
| 06/28/2007 | US20070148714 Clinical Parameters for Determining Hematologic Toxicity Prior to Radioimmunotherapy |
| 06/28/2007 | US20070148092 Compositions and methods for imaging pain and stress in vivo |
| 06/28/2007 | US20070148091 Peptides and compounds that bind to a receptor |
| 06/28/2007 | US20070148090 Per (3,6-anhydro) cyclodextrin derivatives, preparation thereof and use thereof for transporting metal elements to biological targets or for decontaminating biological targets of fluids |